EGFR-Targeted TRAIL and a Smac Mimetic Synergize to Overcome Apoptosis Resistance in KRAS Mutant Colorectal Cancer Cells

TRAIL is a death receptor ligand that induces cell death preferentially in tumor cells. Recombinant soluble TRAIL, however, performs poorly as an anti-cancer therapeutic because oligomerization is required for potent biological activity. We previously generated a diabody format of tumor-targeted TRA...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Möller, Yvonne, Siegemund, Martin, Beyes, Sven, Herr, Ricarda, Lecis, Daniele, Delia, Domenico, Kontermann, Roland, Brummer, Tilman, Pfizenmaier, Klaus, Olayioye, Monilola A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2014
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4157814/
https://ncbi.nlm.nih.gov/pubmed/25198428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0107165
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller